KURA – Kura Oncology, Inc.
Kura Oncology, Inc.KURA
$7.57Name : Kura Oncology, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $673,431,872.00
EPSttm : -3.37
Kura Oncology, Inc.
$7.57
0.00%$0.00000000000000
KURA — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
16.56
Margin Of Safety %
Put/Call OI Ratio
1.24
EPS Next Q Diff
-0.02
EPS Last/This Y
0.01
EPS This/Next Y
0.82
Price
7.57
Target Price
31.85
Analyst Recom
1.19
Performance Q
-23.84
Upside
-1,653.5%
Beta
0.56
Ticker: KURA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | KURA | 10.36 | 0.79 | 5.45 | 25673 |
| 2026-10-13 | KURA | 9.84 | 0.80 | 6.64 | 26122 |
| 2026-10-14 | KURA | 9.62 | 0.81 | 3.01 | 26529 |
| 2026-10-15 | KURA | 9.7 | 0.82 | 2.26 | 26789 |
| 2026-10-16 | KURA | 9.07 | 0.80 | 4.48 | 26637 |
| 2026-10-19 | KURA | 9.36 | 1.03 | 2.88 | 20512 |
| 2026-10-20 | KURA | 9.98 | 1.02 | 3.86 | 21986 |
| 2026-10-21 | KURA | 9.9 | 0.95 | 3.56 | 23568 |
| 2026-10-22 | KURA | 9.85 | 0.95 | 2.60 | 23949 |
| 2026-10-23 | KURA | 9.6 | 0.97 | 1.95 | 24251 |
| 2026-10-26 | KURA | 9.62 | 1.00 | 2.24 | 24852 |
| 2026-10-27 | KURA | 9.89 | 1.01 | 4.94 | 26356 |
| 2026-10-28 | KURA | 10.73 | 1.08 | 1.89 | 27839 |
| 2026-10-29 | KURA | 10.56 | 1.12 | 4.39 | 28779 |
| 2026-10-30 | KURA | 10.27 | 1.20 | 2.34 | 29894 |
| 2026-11-02 | KURA | 9.79 | 1.22 | 3.33 | 31085 |
| 2026-11-03 | KURA | 9.89 | 1.25 | 3.32 | 31970 |
| 2026-11-04 | KURA | 7.6 | 1.30 | 1.04 | 33308 |
| 2026-11-05 | KURA | 6.76 | 1.24 | 29.40 | 33932 |
| 2026-11-06 | KURA | 7.26 | 1.25 | 2.59 | 34505 |
| 2026-11-09 | KURA | 7.55 | 1.21 | 5.94 | 35697 |
| 2026-11-10 | KURA | 7.57 | 1.24 | 5.87 | 36551 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | KURA | 10.41 | 5.2 | - | -3.17 |
| 2026-10-13 | KURA | 9.84 | 5.2 | - | -3.17 |
| 2026-10-14 | KURA | 9.62 | 5.2 | - | -3.17 |
| 2026-10-15 | KURA | 9.70 | 5.2 | - | -3.17 |
| 2026-10-16 | KURA | 9.08 | 5.2 | - | -3.17 |
| 2026-10-19 | KURA | 9.35 | 5.2 | - | -3.17 |
| 2026-10-20 | KURA | 9.35 | 5.2 | - | -3.17 |
| 2026-10-21 | KURA | 9.97 | 5.2 | - | -3.17 |
| 2026-10-22 | KURA | 9.85 | 5.2 | - | -3.17 |
| 2026-10-23 | KURA | 9.60 | 5.2 | - | -3.17 |
| 2026-10-26 | KURA | 9.63 | 5.2 | - | -3.17 |
| 2026-10-27 | KURA | 9.91 | 5.2 | - | -3.17 |
| 2026-10-28 | KURA | 10.74 | 5.2 | - | -3.17 |
| 2026-10-29 | KURA | 10.57 | 5.2 | - | -3.17 |
| 2026-10-30 | KURA | 10.27 | 5.2 | - | -3.17 |
| 2026-11-02 | KURA | 9.79 | 5.2 | - | -3.17 |
| 2026-11-03 | KURA | 9.89 | 5.2 | - | -3.17 |
| 2026-11-04 | KURA | 7.61 | 5.2 | - | -3.17 |
| 2026-11-05 | KURA | 6.76 | 5.2 | - | -3.17 |
| 2026-11-06 | KURA | 7.25 | 5.2 | - | -3.17 |
| 2026-11-09 | KURA | 7.55 | 5.2 | - | -3.17 |
| 2026-11-10 | KURA | 7.57 | 5.2 | - | -3.17 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | KURA | -2.12 | 3.75 | 16.67 |
| 2026-10-13 | KURA | -2.12 | 3.75 | 16.67 |
| 2026-10-14 | KURA | -2.12 | 3.75 | 16.67 |
| 2026-10-15 | KURA | -2.12 | 3.75 | 16.67 |
| 2026-10-16 | KURA | -2.12 | 3.75 | 16.67 |
| 2026-10-19 | KURA | -2.12 | 3.53 | 16.67 |
| 2026-10-20 | KURA | -2.12 | 3.53 | 16.67 |
| 2026-10-21 | KURA | -2.12 | 3.53 | 16.67 |
| 2026-10-22 | KURA | -2.12 | 3.53 | 16.67 |
| 2026-10-23 | KURA | -2.12 | 3.53 | 16.67 |
| 2026-10-26 | KURA | -2.12 | 3.50 | 16.67 |
| 2026-10-27 | KURA | -2.12 | 3.50 | 16.56 |
| 2026-10-28 | KURA | -2.12 | 3.50 | 16.56 |
| 2026-10-29 | KURA | -2.12 | 3.50 | 16.56 |
| 2026-10-30 | KURA | -2.12 | 3.50 | 16.56 |
| 2026-11-02 | KURA | -2.12 | -0.99 | 16.56 |
| 2026-11-03 | KURA | -2.12 | -0.99 | 16.56 |
| 2026-11-05 | KURA | -2.12 | -0.99 | 16.56 |
| 2026-11-06 | KURA | -2.12 | -0.99 | 16.56 |
| 2026-11-09 | KURA | -2.12 | -1.66 | 16.56 |
| 2026-11-10 | KURA | -2.12 | -1.66 | 16.56 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.77
Avg. EPS Est. Current Quarter
-0.81
Avg. EPS Est. Next Quarter
-0.79
Insider Transactions
-2.12
Institutional Transactions
-1.66
Beta
0.56
Average Sales Estimate Current Quarter
23
Average Sales Estimate Next Quarter
33
Fair Value
Quality Score
35
Growth Score
24
Sentiment Score
4
Actual DrawDown %
68.7
Max Drawdown 5-Year %
-76.5
Target Price
31.85
P/E
Forward P/E
PEG
P/S
8.72
P/B
13.9
P/Free Cash Flow
EPS
-3.36
Average EPS Est. Cur. Y
-3.17
EPS Next Y. (Est.)
-2.34
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-384.3
Relative Volume
1.16
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
KURA
Healthcare
$7.57
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
32.7
Range 1M
17.4%
Sup Dist
5.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-1.9%
EPS NY
25.4%
52W%
10.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+320.7% upside
Upside
+320.7%
Quality
35
KURA — P/E HistoricalBiotechnology
Kura Oncology, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 260
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
KURA
Latest News
—
Caricamento notizie per KURA…
stock quote shares KURA – Kura Oncology, Inc. Stock Price stock today
news today KURA – Kura Oncology, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KURA – Kura Oncology, Inc. yahoo finance google finance
stock history KURA – Kura Oncology, Inc. invest stock market
stock prices KURA premarket after hours
ticker KURA fair value insiders trading